Home | MyCME | All CME | Blog | Psychlopedia
All Available CME Activities
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaYou can help your patients with schizophrenia achieve the ultimate goal of treatment—recovery. Learn how to use patient-centered care to enhance medication adherence and aid functional recovery. [top]

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Patient-Centered Psychopharmacology and Psychosocial Interventions: Treatment Selection and Shared Decision-Making to Enhance Chances for Recovery

John Lauriello, MD

Using Patient-Centered Assessment in Schizophrenia Care: Defining Recovery and Discussing Concerns and Preferences

Christoph U. Correll, MD

Current Treatment Options and Emerging Agents for Schizophrenia

Christoph U. Correll, MD

Prevalence and Impact of Relapse in Patients With Schizophrenia

John Lauriello, MD

Identifying and Treating Insomnia in Patients Living with Alzheimer’s Disease

Identifying and Treating Insomnia in Patients Living with Alzheimer’s Disease

Alon Y. Avidan, MD, MPH, and Anna D. Burke, MD

Measurement-Based Care for Depression From Screening and Assessment Through Treatment

Major Depressive Disorder in Primary Care: Strategies for Identification

Madhukar H. Trivedi, MD

How Can Measurement-Based Care Help Improve Treatment Outcomes for Major Depressive Disorder in Primary Care?

Madhukar H. Trivedi, MD

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Medication Options and Clinical Strategies for Treating Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

Identifying Tardive Dyskinesia: Risk Factors, Functional Impact, and Diagnostic Tools

Stephen R. Saklad, PharmD, BCPP

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Treatment Strategies for Tardive Dyskinesia

Daniel E. Kremens, MD, JD

Earlier Diagnosis of Tardive Dyskinesia

Daniel E. Kremens, MD, JD

FDA-Approved Medications to Treat Tardive Dyskinesia

Joseph P. McEvoy, MD

Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia

Joseph P. McEvoy, MD

Strategies for Acute and Maintenance Treatment of Bipolar I Disorder

Strategies for Shifting From Acute to Maintenance Treatment for Bipolar I Disorder

Trisha Suppes, MD, PhD

Evidence-Based Treatment Targets, Selection, and Strategies for Acute Manic and Mixed Episodes of Bipolar I Disorder

Trisha Suppes, MD, PhD

Earlier Diagnosis and Expanded Treatment Options for Patients With Parkinson Disease

Effective Treatment Strategies for Motor and Nonmotor Symptoms of Parkinson Disease

Stuart H. Isaacson, MD

Early Recognition and Diagnosis of Parkinson Disease and Ongoing Assessments

Stuart H. Isaacson, MD

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

A Multidisciplinary Approach for Addressing Challenges in Alzheimer's Disease

Alireza Atri, MD, PhD; Simon Sheard, DO; and Danielle Goldfarb, MD

Cognitive Assessment of Alzheimer’s Disease and Dementias in Clinical Practice: Pragmatics of Brief Instruments and Neuropsychological Evaluation

Lynn Shaughnessy, PsyD; Simon Sheard, DO; Danielle Goldfarb, MD; and Alireza Atri, MD, PhD

Disclosure of Alzheimer’s Disease and Dementia: Patient- and Care Partner-Centric Decision-Making and Communication

Danielle Goldfarb, MD; Simon Sheard, DO; Lynn Shaughnessy, PsyD; and Alireza Atri, MD, PhD

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

New Mechanisms, New Opportunities: Integrating Novel Antidepressants in the Treatment of Major Depressive Disorder

Leslie Citrome, MD, MPH; James W. Murrough, MD, PhD; Joseph F. Goldberg, MD; Bradley N. Gaynes, MD, MPH; and Terence Ketter, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

John Lauriello, MD and Diana O. Perkins, MD

Overcoming Challenges in Diagnosis and Depression Management in Pediatric Bipolar Disorder

Treating Bipolar Disorder in Pediatric Patients and Educating Patients and Parents

Melissa P. DelBello, MD, MS

Using Screening Tools and Diagnosing Bipolar Disorder in Pediatric Patients

Manpreet K. Singh, MD, MS

Current and Emerging Treatments to Address Unmet Needs in MDD

Current and Emerging Treatments to Address Unmet Needs in MDD

Michael E. Thase, MD

Improving the Diagnosis and Treatment of Adolescent Bipolar Disorder

Diagnosing Bipolar Disorder in Pediatric Patients

Kiki D. Chang, MD

Treating Bipolar Disorder in Adolescents

Robert L. Findling, MD, MBA

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

CME From JCPIn this journal CME activity, find experts’ recommendations for reducing schizophrenia relapse, such as adopting a patient-centered approach, selecting medications based on current evidence, and implementing psychosocial interventions. [top]

The Schizophrenia Remission Roller Coaster: Using Long-Acting Injectable Antipsychotics to Improve Adherence and Enhance Potential for Functional Recovery

Using Long-Acting Injectable Antipsychotics to Enhance Potential for Recovery From Schizophrenia

Christoph U. Correll, MD, John Lauriello, MD

JCP CME Activities

Efficacy, effect on mood symptoms, and safety of deep brain stimulation in refractory obsessive-compulsive disorder: a systematic review and meta-analysis

Filipe Peste Martinho, Gonçalo Silva Duarte, Frederico Simões do Couto

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie

Georgios Schoretsanitis, John M. Kane, Christoph U. Correll, Stephen R. Marder, Leslie Citrome, John W. Newcomer, Delbert G. Robinson, Donald C. Goff, Deanna L. Kelly, Oliver Freudenreich, Daria Piacentino, Michael Paulzen, Andreas Conca, Gerald Zernig, Ekkehard Haen, Pierre Baumann, Christoph Hiemke, Gerhard Gründer, for the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrier

New-Onset Delusions Heralding an Underlying Neurodegenerative Condition: A Case Report and Review of the Literature

Emily A. Ferenczi; Michael G. Erkkinen; Mel B. Feany; Barry S. Fogel; Kirk R. Daffner

Disordered Aggression and Violence in the United States

Emil F. Coccaro, and Royce J. Lee

The Value of Neuropsychological Assessment in the Differentiation Between Behavioral Variant Frontotemporal Dementia and Late-Onset Psychiatric Disorders

Jozefien M. Overbeek; Nicole Korten; Flora Gossink; Jay Fieldhouse; Marleen van de Beek; Lianne Reus; Annemieke Dols; Yolande Pijnenburg; and Sigfried Schouws

Past Psychiatric Conditions as Risk Factors for Postpartum Depression: A Nationwide Cohort Study

Sara L. Johansen; Ben A. Stenhaug; Thalia K. Robakis; Katherine E. Williams; and Mark R. Cullen

Predicting Remission in Late-Life Major Depression: A Clinical Algorithm Based Upon Past Treatment History

Erica L. F. Buchalter; Hanadi Ajam Oughli; Eric J. Lenze; David Dixon; J. Philip Millera; Daniel M. Blumberger; Jordan F. Karp; Charles F. Reynolds III; and Benoit H. Mulsant

Prescription Opioid Misuse in US Older Adults: Associated Comorbidities and Reduced Quality of Life in the National Epidemiologic Survey of Alcohol and Related Conditions-III

Ty S. Schepis, and Sean Esteban McCabe

Real World Outcomes in the Management of Refractory Psychosis

Amir Krivoy; Dan Joyce; Derek Tracy; Fiona Gaughran; James MacCabe; John Lally; Whiskey Eromona; S. Neil Sarkar, and Sukhwinder S. Shergill

Early Stabilization of Weight Changes Following Treatment With Olanzapine, Risperidone, and Aripiprazole: A 12-Month Naturalistic Study of First Episode Psychosis

Sally Mustafa; Ridha Joober; Srividya Iyer; Jai Shah; Martin Lepage; Ashok Malla

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder

Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A. Axelson; Daniel P. Dickstein, MD; Tina R. Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D. Ryan; Michael A. Strober; Martin B. Keller; and Benjamin I. Goldstein

Benzodiazepine Use During Pregnancy Alone or in Combination With an Antidepressant and Congenital Malformations: Systematic Review and Meta-Analysis

Sophie Grigoriadis; Lisa Graves; Miki Peer; Lana Mamisashvili; Cindy-Lee Dennis; Simone N. Vigod; Meir Steiner; Cara Brown; Amy Cheung; Hiltrud Dawson; Neil Rector; Melanie Guenette; and Margaret Richter

Treatment of Common Mental Disorders in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III

Mark Olfson, Carlos Blanco, Melanie M. Wall, Shang-Min Liu, and Bridget F. Grant

Sex and Pubertal Status Moderate the Association Between ADHD and Depression Symptoms: An Examination from Preadolescence Through Late Adolescence

Dara E. Babinski, Daniel A. Waschbusch, and James G. Waxmonsky

Correlates of Opioid Abstinence in a 42-Month Posttreatment Naturalistic Follow-Up Study of Prescription Opioid Dependence

Roger D. Weiss, Margaret L. Griffin, David E. Marcovitz, Blake T. Hilton, Garrett M. Fitzmaurice, R. Kathryn McHugh, and Kathleen M. Carroll

Sexually Transmitted Infection Among Adolescents and Young Adults With Bipolar Disorder: A Nationwide Longitudinal Study

Mu-Hong Chen, Han-Ting Wei, Ya-Mei Bai, Kai-Lin Huang, Nai-Ying Ko, Tung-Ping Su, Cheng-Ta Li, Wei-Chen Lin, Shih-Jen Tsai, Tzeng-Ji Chen, and Ju-Wei Hsu

Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis

Eric T. Dobson, Michael H. Bloch, and Jeffrey R. Strawn

Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort

David Misdrahi, Arnaud Tessier, Antoine Daubigney, Wassilios G. Meissner, Franck Schurhoff, Laurent Boyer, Ophélia Godin, Ewa Bulzacka, Bruno Aouizerate, Meja Andrianarisoa, Fabrice Berna, Delphine Capdevielle, Isabelle Chereau-Boudet, Thierry D’Amato, Caroline Dubertret, Julien Dubreucq, Catherine Faget-Agius, Christophe Lançon, Jasmina Mallet, Christine Passerieux, Romain Rey, Aurélie Schandrin, Mathieu Urbach, Pierre Vidailhet, Pierre-Michel Llorca, and Guillaume Fond for the FACE-SZ (FondaMental Academic Centers of Expertise for Schizophrenia) Group

Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults

Soham Rej, Nathan Herrmann, Andrea Gruneir, Racquel Jandoc, Eric McArthur, Stephanie Dixon, and Amit X. Garg

A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts

An Examination of Screening Tools for Collaborative Care of Adolescent Depression

Alexander D. Ginsburg, Paul S. Stadem, Christopher R. Takala, Paul E. Croarkin, Angela B. Mattson, Marcie L. Billings, RoxAnne M. Brennan, and John E. Huxsahl

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Revisiting Tardive Dyskinesia: Focusing on the Basics of Identification and Treatment

Leslie Citrome, MD, MPH; Stephen R. Saklad, PharmD, BCPP

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia

Joseph P. McEvoy, MD, and Daniel E. Kremens, MD, JD

A Multidisciplinary Approach for Addressing Challenges in Alzheimer’s Disease

Current and Emerging Solutions to Challenges in the Evaluation and Management of Alzheimer’s Disease

Alireza Atri, MD, PhD (Chair); Danielle Goldfarb, MD; Simon Sheard, DO; and Lynn Shaughnessy, PsyD

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

John M. Kane, MD, and Christoph U. Correll, MD

Managing Transitions in Care and Adherence to Improve Outcomes in Schizophrenia

Enhancing the Treatment of Patients With Schizophrenia Through Continuous Care

John Lauriello, MD, and Diana O. Perkins, MD

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD (Chair), et al

JCP SupplementAre you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement by 2 experts in the field for an update on PDP symptoms and treatments. [top]

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Rajesh Pahwa, MD (Chair), and Daniel E. Kremens, MD, JD

CME From PCCIn addition to psychosis, depressive symptoms can occur in patients with anti-NMDAR encephalopathy (ANMDARE). ANDMARE should be considered in patients presenting with psychotic or atypical depressive illnesses. Early recognition of ANMDARE could lead to better management of this potentially life-threatening autoimmune disorder. [top]

PCC CME Activities

Psychiatric Prodrome in Anti-NMDAR–Associated Encephalopathy: Clinical and Pathophysiologic Considerations

Anh-Vu Nguyen, Keith A. Young, James A. Bourgeois

Organic Psychosis Causing Secondary Schizophrenia in One-Fourth of a Cohort of 200 Patients Previously Diagnosed With Primary Schizophrenia

João Gama Marques

Glucagon-Like Peptide Analogues Are Superior for Diabetes and Weight Control in Patients on Antipsychotic Medications: A Retrospective Cohort Study

Lauren T. Perlis; J. Steven Lamberti; and Susanne U. Miedlich

Hypertensive Urgency and Emergency in Alcohol Withdrawal: A Literature Review

Ermal Bojdani, Anderson Chen, Tina Zhang, Nida Naqvi, Dil Tahera

No MMSE for You! A case of an ‘uncooperative’ patient with early-onset dementia

Po-Heng Tsai, Gurmehr Kaur, Ganesh Gopalakrishna

Bridging Community Mental Health and Primary Care to Improve Medication Monitoring and Outcomes for Patients With Mental Illness Taking Second-Generation Antipsychotics (HDC/DFMC Bridge Project—Phase 1: Group Concept Mapping)

Keri Hager; Margarette Kading; Carolyn O’Donnell; Ann Yapel; Danielle MacDonald; Jennifer Nelson Albee; Cynthia Nash; Colleen Renier; Katherine Dean; and Mark Schneiderhan

Lithium Neurotoxicity Due to Second-Generation Antipsychotics Combined With Lithium: A Systematic Review

Ivan Netto, Vivek H. Phutane, and Bipin Ravindran

Posttraumatic Stress Disorder Symptoms, Functioning, and Suicidal Ideation in US Military Veterans: A Symptomics Approach

Lorig K. Kachadourian, Ilan Harpaz-Rotem, Jack Tsai, Steven M. Southwick, and Robert H. Pietrzak

Psychotropic Medication Monitoring: A Review

Matthew A. Schreiber, Stephanie C. Armstrong, and Jesse D. Markman

Stimulant Formulations for the Treatment of Attention-Deficit/Hyperactivity Disorder

Mohan Gautam and Deepak Prabhakar

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD

Posttraumatic Stress Disorder Comorbid with Mood Disorder: Significantly Higher Incidence of Obstructive Sleep Apnea Than Either Diagnosis Alone

Bettina S. Fehr, William F. Katz, Erin A. Van Enkevort, and Imran S. Khawaja

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments

Migraine Headache: Diagnosis and Current and Emerging Preventive Treatments

Richard B. Lipton, MD, and Stephen Silberstein, MD

 
​​​
​​​​​​​